A new era in noninvasive prenatal testing [3]

New England Journal of Medicine

Volumn 369, Issue 22, 2013, Pages 2164-2165

  Ashwood, Edward R ^a   Palomaki, Glenn E ^b  

^a ARUP LABORATORIES   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CELL FREE SYSTEM; COHORT ANALYSIS; DOWN SYNDROME; FETUS WASTAGE; FOOD AND DRUG ADMINISTRATION; HIGH RISK PREGNANCY; HUMAN; LETTER; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; TRISOMY 13; TRISOMY 18; VALIDITY; ANEUPLOIDY; CHROMOSOME 21; FETUS DISEASE; SCREENING TEST; VALIDATION STUDY;

EID: 84888346812     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1311604     Document Type: Letter

References (2)

1. Morain S, Greene MF, Mello MM. A new era in noninvasive prenatal testing. N Engl J Med 2013;369:499-501. [Erratum, N Engl J Med 2013;369:683.]
2. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-4.